Improving Protein Production in CHO Cells - Biopharmaceutical protein manufacture can benefit from using chemically defined feeds in CHO cell lines. - BioPharm International

ADVERTISEMENT

Improving Protein Production in CHO Cells
Biopharmaceutical protein manufacture can benefit from using chemically defined feeds in CHO cell lines.


BioPharm International Supplements


Bioreactor Studies


Figure 3
To determine the effects different feeds had on cell numbers and protein expression, a 15-L stir-tank bioreactor (Applikon Biotechnology, Foster City, CA) containing CD CHO medium was inoculated with a different proprietary recombinant IgG CHO cell line at 3 x 105 cells/mL. The pH and dissolved oxygen were set at 6.9 and 50%, respectively, with agitation at 150–175 rpm. The CO2 and oxygen sparge rates were both set at 100 mL/minute. Glucose was added to 6 g/L if the concentration in the media in the bioreactor fell to less than 2 g/L. GS-Max (HyClone, Logan, UT) was fed at 1% of starting volume if the level of glutamate fell to less than 1.5 mM, as occurred in all bioreactors. Four different feed strategies were carried out over 10 days. In one bioreactor (Figure 3), 3% v/v addition of soy hydrolysate was added from a stock of 40 g/L every day for 10 days. In another bioreactor (Figure 4), a 3% v/v solution of chemically defined feed A, (CHO CD EfficientFeed A) was added on days 0–5 followed by addition on days 6–10 of daily supplementation of a 3% v/v solution of chemically defined feed B, (CHO CD EfficientFeed B). The additional two feed strategies determined the effects of higher concentrations of the chemically defined feeds but at fewer time points: 1) a 10% v/v solution of chemically defined feed A was added on days 0 and 3, followed by a 10% v/v solution of chemically defined feed B on days 6, 9, and 2) a 15% v/v solution of feed A was added on day 0 followed by addition of a 15% v/v solution of feed B on day 6. Both total cell counts and protein titers, as determined by ELISA over 13 days, are presented in the results (Figures 3 and 4).


blog comments powered by Disqus

ADVERTISEMENT

Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
May 13, 2013
Amgen Forms New Joint Venture to Commercialize Vectibix in China
May 13, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International Supplements,
Click here